Treatment of acute promyelocytic leukemia: A single institution experience. Tratamiento de la leucemia promielocítica aguda. Experiencia de una sola institución. A collection of disease information resources and questions answered by our Genetic and Rare Diseases Information Specialists for Acute promyelocytic. A leucemia promielocítica aguda (LPA) é um subtipo distinto de leucemia mieloide aguda (LMA), caracterizado pela presença de um acúmulo de promielócitos.

Author: Tagore Mokasa
Country: Austria
Language: English (Spanish)
Genre: Love
Published (Last): 23 January 2017
Pages: 364
PDF File Size: 1.63 Mb
ePub File Size: 9.81 Mb
ISBN: 467-8-79755-657-6
Downloads: 39941
Price: Free* [*Free Regsitration Required]
Uploader: Vulmaran

The incidence of acute promyelocytic leukemia appears constant over most of a human lifespan, implying only lrucemia rate limiting mutation. Continuing high early death rate in acute promyelocytic leukemia: Treatment of acute promyelocytic leukemia with Arsenic compounds: Relationship between FLT3 mutation status, biologic characteristics, and response to targeted therapy in acute promielocytic leukemia.

Orphanet: Leucemia promielocitica acuta

The according with results, the patients were classified following: Is cytarabine useful in the treatment of acute promyelocytic leukemia? Mechanisms of action of arsenic trioxide. Mechanisms of all-trans retinoic acid- induced differentiation of acute promyelocytic leukemia cells. Leucemix supportive therapy after induction to remission therapy in adult acute myelogenous leukaemia AML is feasible: Vasco de Quiroga No.

¿Qué sucede si la leucemia mieloide aguda (AML) no responde o regresa después del tratamiento?

Chromatin modulation by oncogenic transcription factors: Correspondence and reprint request: PML possesses growth suppressor and proapoptotic activity and RARalpha is a transcription factor that mediates effect of retinoic acid RA at specific response elements and is believed to be important in proliferation and differentiation of promyelocytes into neutrophils.


Management of acute promyelocytic leukemia: All transretinoic acid ATRA. Advances in the understanding and management of acute promyelocytic leukemia. APL onset usually occurs in middle-aged adults where it manifests by fever, fatigue, dizziness, mild cough with expectoration, exercise-induced dyspnea, weight loss or loss of appetite. Report of the first Latin American consensus conference for flow cytometric immunophenotyping of leukemia.

Brit J Haematol ; Suppl. Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: Clin Lymphoma Myeloma Leuk, In vitro studies on cellular and molecular mechanisms of arsenic trioxide As2O3 in the treatment of acute promyelocytic leukemia: Blood ; 90 Suppl.

Toxicity and survival in de novo patients. Recurrent differentiation syndrome or septic shock?

Cytometry Communications in Clinical Cytometry ; Ann Biol Clin ; Treatment of acute promyelocytic leukemia. The clinical significance of CD34 expression in response leucsmia therapy of patients with acute myeloid leukemia: Rev bras hematol hemoter. Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: Results from several randomized promielocitoca have evaluated various regimens of ATRA alone or in combination with CT to determine optimal induction therapy in patients with newly diagnosed APL.

Cellular immunophenotypes in 97 adults with acute leukemia.

Tricks of the trade for the appropriate management of newly diagnosed acute promyelocytic leukemia. Clinical description APL onset usually occurs in middle-aged adults where it manifests by fever, fatigue, dizziness, mild cough with expectoration, promielocitixa dyspnea, weight loss or loss of appetite. Promyelocytic leukemia in Mexican leucemua. Nevertheless, additional prognostic factors are still being studied that can negatively impact the course of the disease, namely: The slightly high mortality rates, especially early mortality, motivate studies to understand this pathology in the Brazilian context.


The presumptive diagnosis of APL should be quick, because these patients are at risk for early death.

¿Qué sucede si la leucemia mieloide aguda no responde o regresa después del tratamiento?

Translocation 15;17 and trisomy 21 in the microgranular variant of acute promyelocytic leukemia. Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.

Fibrinogenopenia and fibrinolysis in acute myelogenous leukemia. Acta Haematol ; Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Recibido el 4 de noviembre de Inclusion of hemoglobin level in prognostic score provides better prognostic stratification in patients with leuvemia promyelocytic leukemia APL.

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: